Skip to main content

Published locations for Phase 1 study: Beta-blocker may improve melanoma treatment response

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 1 study: Beta-blocker may improve melanoma treatment response

User login

  • Reset your password
  • /content/phase-1-study-beta-blocker-may-improve-melanoma-treatment-response
  • /edermatologynews/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma-treatment
  • /internalmedicinenews/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma
  • /oncologypractice/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma-treatment
  • /psychiatry/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma-treatment
  • /hematology-oncology/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma
  • /internalmedicine/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma-treatment
  • /dermatology/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma-treatment
  • /clinicalpsychiatrynews/article/233166/melanoma/phase-1-study-beta-blocker-may-improve-melanoma